Bio-Gene Technology Limited (ASX:BGT)

Australia flag Australia · Delayed Price · Currency is AUD
0.0350
0.00 (0.00%)
Mar 9, 2026, 3:03 PM AEST
2.94%
Market Cap 10.68M
Revenue (ttm) n/a
Net Income (ttm) -2.52M
Shares Out 305.06M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 31,823
Average Volume 80,149
Open 0.0380
Previous Close 0.0350
Day's Range 0.0350 - 0.0380
52-Week Range 0.0160 - 0.0610
Beta 0.83
RSI 66.15
Earnings Date Apr 27, 2026

About Bio-Gene Technology

Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural plant-derived oil with high levels of tasmanone. The company has a research collaboration agreement with James Cook University for experiments demonstrating the value of pre-conditioning biomass prior to distillation; Cesar for assessing the insecticidal activ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1995
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol BGT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.